RecruitingEarly Phase 1NCT04838678

Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

Sympathetic Neural Patterns and Transduction in Obesity-associated Hypertension


Sponsor

University of Texas Southwestern Medical Center

Enrollment

100 participants

Start Date

Jul 18, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to understand how the nervous system communicates to blood vessels to increase blood pressure during stress. The study will also investigate how hypertension and obesity influence the nervous system and vascular function. The study will involve measuring sympathetic nervous system activity and blood flow during common laboratory physiological stress protocols (e.g. hypoxia, exercise), and in response to infusion of drugs that cause vasodilation or vasoconstriction.


Eligibility

Min Age: 18 YearsMax Age: 55 Years

Inclusion Criteria2

  • Control - BMI\<30, age 18-55
  • Hypertensive - BMI\<30, age 18-55, diagnosis of hypertension by 24-hour ambulatory blood pressure monitoring Obese- BMI\>30, age 18-55 Obese-hypertensive- BMI\>30, age 18-55, diagnosis of hypertension by 24-hour ambulatory blood pressure monitoring

Exclusion Criteria1

  • All groups - presence of other significant cardiovascular disease, renal disease, history of smoking, diabetes,

Interventions

DRUGNeuropeptide Y

intra-arterial infusion of neuropeptide Y


Locations(1)

University of Texas Southwestern Medical Center

Dallas, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04838678


Related Trials